title: [Malignant central nervous system tumors are susceptible to specific antibodies].
abstract: The binding of circulating specific IgG to glioblastoma cells from brain tumor biopsies was shown using fluorescence conjugate Protein A-FITC and Western blotting. Blood-brain barrier permeability for antitumor antibodies in vivo in glioblastoma patients is suggested.
authors.affiliation: St. Petersburg Institute of Nuclear Physics, Russian Academy of Sciences, Gatchina.
authors.forename: O P
authors.initials: OP
authors.lastname: Blizniukov
authors.forename: L D
authors.initials: LD
authors.lastname: Kozmin
authors.forename: V E
authors.initials: VE
authors.lastname: Oliushin
authors.forename: O V
authors.initials: OV
authors.lastname: Ostreĭko
authors.forename: M V
authors.initials: MV
authors.lastname: Filatov
mesh_terms: D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D015153:Blotting, Western; D001932:Brain Neoplasms / Q000276:immunology* / Q000628:therapy*; D016650:Fluorescein-5-isothiocyanate; D005910:Glioma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000912:Antibodies, Neoplasm; D007074:Immunoglobulin G; D016650:Fluorescein-5-isothiocyanate